India TB Report-2024: 16 percent decline in new cases since 2015
New Delhi: India has witnessed a 16 per cent decline in Tuberculosis (TB) incidence (new cases emerging each year) and an 18 per cent reduction in mortality due to the disease since 2015, according to the annual India TB report.
A significant rise in tuberculosis (TB) cases, with over 25.55 lakh cases notified in the previous year, marking the highest ever since the inception of the National Tuberculosis Elimination Programme (NTEP) in the 1960s, as per a government report. Notably, nearly 32 per cent of these notified cases emanated from the private healthcare sector.
According to the India TB report for the year 2024, a staggering 8.4 lakh TB cases were reported from the private sector alone, reflecting a notable 17 percent increase from the figures recorded in 2022. This surge in private sector cases underscores the growing contribution of private healthcare facilities in TB case detection.
"The country continued the consistent trend of improvement in case finding in 2023, as demonstrated by the notification of 25.55 lakh TB cases and a total Annualised TB case notification rate (ACNR) of 178.8 per lakh population which is the highest ever achieved by India," the India TB report 2024 said.
ACNR is the number of TB cases notified per lakh population on an annual basis.
Also Read:Dr Kuldeep Singh Sachdeva highlights Diagnostic and treatment delays in TB
Significantly, the Case Notification Rate (CNR) in the private sector reached 59.2 cases per lakh population, marking the highest ever achievement under the NTEP, as highlighted in the report.
India's relentless efforts to ensure early detection and prompt treatment initiation have yielded commendable results, with a 16 per cent decline in TB incidence and an 18 per cent reduction in TB-related mortality since 2015.
According to the report, TB mortality was 23 per lakh population with 18 per cent decline as compared to 2015 (28 per lakh population), news agency PTI reported.
India's robust healthcare infrastructure has facilitated impressive treatment coverage, with over 80 per cent of estimated TB cases receiving treatment, positioning the country favourably among high-burden TB nations.
However, the report also underscores challenges, including estimates of catastrophic health expenditures affecting 15 per cent or more of the population since 2000.
Estimates of the percentage of the population facing catastrophic health expenditures were greater than or equal to 15 per cent of the population for India, showing an upward trend since 2000, the report said.
"The treatment coverage had improved to 80 per cent of the estimated TB cases, an increase of 19 per cent over the previous year," the report said.
According to PTI, "In 2024, a key indicator case notifications reached a record number: over 25.5 lakh cases were reported, thereby closing the gap between the estimated and reported cases this gap in numbers was more than 10 lakhs in 2015 and we have managed to close this gap to less than 3 lakh by 2023," the health ministry said.
Uttar Pradesh emerged as the state with the highest number of TB notifications, closely followed by Bihar, signaling the need for intensified efforts in these regions.
In 2023, more than 20.5 crore individuals underwent screening for TB symptoms as a part of active case-finding efforts. Of those screened, 1.1 per cent (21.8 lakh) were examined and tested for TB and 35,438 cases (1.6 per cent out of those tested) were diagnosed.
Also Read:World TB Day: Artemis Hospital organizes public awareness workshop
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.